Tower Research Capital (TRC)’s Baird Medical Investment Holdings BDMD Stock Holding History
Bought
Maintained
Sold
Other funds holding BDMD
HCM
PC
VF
WAM
Tower Research Capital (TRC)'s BDMD Position: Q3 2025 in Review
Tower Research Capital (TRC) sold out of Baird Medical Investment Holdings (BDMD) in Q3 2025, closing a stake of 241 shares — an estimated $883 sold.
Tower Research Capital (TRC) first reported a position in BDMD in Q4 2024 and held it in 2 quarters. The position peaked at $2.26K in Q4 2024. 8 funds tracked by Wall St. Rank hold BDMD as of Q3 2025.
- Tower Research Capital (TRC) reported no remaining Baird Medical Investment Holdings position as of Q3 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 241 Baird Medical Investment Holdings shares in Q3 2025, an estimated $883.
- Tower Research Capital (TRC) first reported a position in Baird Medical Investment Holdings in Q4 2024 and held it in 2 quarters.
- Tower Research Capital (TRC)'s Baird Medical Investment Holdings position peaked at $2.26K in Q4 2024.
- 8 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q3 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.